FDA Opioids Plan Not Enough To Unblock Califf
This article was originally published in Scrip
Executive Summary
After coming under fire for failing to do enough to address the explosion in misuse, abuse and addiction to prescription opioids in the US, the FDA on Feb. 4 said it was overhauling its policies with the aim of "reversing the epidemic, while still providing patients in pain access to effective relief."